Farklı Kronik Böbrek Hastalığı Evrelerinde Perkütan Nefrolitotominin Operatif Sonuçları

Year 2020, Volume: 3 Issue: 3, 223 - 229, 31.12.2020

Nebil Akdogan , Mutlu Deger , Volkan İzol , Yıldırım Bayazıt İbrahim Atilla Arıdoğan

Abstract

Amaç:
Kronik böbrek hastalığının (KBH) farklı evrelerinde yapılan perkütan nefrolitotomi (PCNL) sonuçlarını karşılaştırmayı amaçladık.
Gereç ve Yöntemler:
Preoperatif eGFR düzeyleri 90 ml / dak / 1.73 m2'nin altında olan ve PCNL uygulanan 208 hasta retrospektif olarak incelendi. Hastalar GFR düzeylerine göre üç gruba ayrıldı.
Grup A: eGFR 60-90 ml / dak / 1.73 m2, aşama II CKD,
Grup B: eGFR = 30-59 ml / dak / 1.73 m2, evre III CKD,
Grup C: eGFR <30 ml / dak / 1.73 m2, aşama IV / V CKD.
PCNL sonuçları gruplar arasında karşılaştırıldı.
Bulgular:
A, B ve C gruplarında klinik olarak anlamlı olmayan taşsızlık oranları sırasıyla% 91,4,% 88,9 ve% 86,6 idi ve gruplar arasında anlamlı fark yoktu (p = 0,56, 0,40 ve 0.67, sırasıyla). Üç grup arasında komplikasyonlar açısından anlamlı fark görülmedi ve en sık görülen komplikasyonlar transfüzyon gerektiren kanama (% 12,5) ve ateş (% 12,1) idi (p> 0,05). Her üç grupta da birer hastaya kontrolsüz hematüri nedeniyle anjiyoembolizasyon yapıldı.
Sonuç:
KBH ve üriner taş hastalığı önemli halk sağlığı problemleridir. Bu hasta grubu hakkında daha fazla bilgi edinmek için daha fazla çalışmaya ihtiyaç vardır

Keywords

böbrek taşı, Kronik böbrek hastalığı, perkütan nefrolitotomi

Operative Outcomes of Percutaneous Nephrolithotomy in Different Chronic Kidney Disease Stages

Abstract

References

• 1. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the World.World J Urol. 2017 Sep;35(9):1301-1320. doi: 10.1007/s00345-017-2008-6.
• 2. Marangella M, Bruno M, Cosseddu D et al. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990 Jul 1;54(4):302-6.
• 3. Kukreja R, Desai M, Patel SH, et al. Nephrolithiasis associated with renal insufficiency: Factors predicting outcome. J Endourol. 
2003;17:875-879 

• 4. Yanaral F, Ozgor F, Savun M, Sahan M, Sarilar O, Binbay M. Comparison of CROES, S.T.O.N.E, and Guy's scoring systems for the prediction of stone-free status and complication rates following percutaneous nephrolithotomy in patients with chronic kidney disease. Int Urol Nephrol. 2017 Sep;49(9):1569-1575. doi: 10.1007/s11255-017-1631-x
• 5. Akman T, Binbay M, Aslan R et al. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience. The Journal of urology. 2012 Jan 31;187(1):173-7.
• 6. Kurien A, Baishya R, Mishra S, et al. The impact of percutaneous nephrolithotomy in patients with chronic kidney disease. J Endourol. 2009;23:1403-7.
• 7. Raj GV, Auge BK, Weizer AZ, Denstedt JD, Watterson JD, Beiko DT, Assimos DG and Preminger GM. Percutaneous management of calculi within horseshoe kidneys. J Urol 2003; 170: 48-51
• 8. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
• 9. Rule AD, Bergstralh EJ,MeltonLJ,etal.Kidneystonesandtherisk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804-811.
• 10. Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D'Addessi A, Ferraro PM. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review. J Urol. 2017 Aug;198(2):268-273. doi: 10.1016/j.juro.2016.12.135. Epub 2017 Mar 10.
• 11. Gupta M, Bolton DM, Gupta PN, Stoller ML. Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol. 1994;152:1086-90.
• 12. Gambaro G, D’Angelo A, Favaro S. Risk for renal failure in nephrolithiasis. Am J Kidney Dis. 2001;37:233-43.
• 13. Bilen CY, Inci K, Kocak B, et al. Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with 
chronic kidney disease. J Endourol. 2008;22:895-900.
• 14. Yaycioglu O, Egilmez T, Gul U, Turunc T, Ozkardes H. Percutaneous nephrolithotomy in patients with normal versus impaired renal function. Urol Res. 2007;35:101-5.
• 15. Etemadian M, Maghsoudi R, Shadpour P, Ghasemi H, Shati M. Outcomes of tubeless percutaneous nephrolithotomy in patientswith chronic renal insufficiency. Iran J Kidney Dis. 2012 May;6(3):216-8.
• 16. Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J (2016) GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients. Int Urol Nephrol 48:839–844
• 17. Cader RA, Ibrahim OA, Paul S, Gafor HA, Mohd R (2014) Left ventricular hypertrophy and chronic fluid overload in peritoneal dialysis patients. Int Urol Nephrol 46:1209–1215
• 18. Sairam K, Scoffone CM, Alken P et al. Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. The Journal of urology. 2012 Oct 31;188(4):1195-200.
• 19. Seitz C, Desai M, Häcker A, et al. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. European urology. 2012 Jan 31;61(1):146-58.